Jessica Fay Ali
Adult Health · New York, NYNPI 1063146140
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.4% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,831, 4.8 times the $379 reported in 2022. Among adult health clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $23.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$927
- Johnson & Johnson$477
- Sanofi$455
- Genentech USA, Inc.$310
- AbbVie$248
- Bristol Myers Squibb$228
- plus $2K from 36 others
What the payments were for
- Consulting fees$1754%
- Food & beverage$4,60494%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 38 | $927 |
| Johnson & Johnson | 19 | $477 |
| Sanofi | 14 | $455 |
| Genentech USA, Inc. | 19 | $310 |
| AbbVie | 10 | $248 |
| Bristol Myers Squibb | 11 | $228 |
| Lilly USA, LLC | 10 | $219 |
| Seagen Inc. | 5 | $192 |
| Sobi, Inc | 8 | $164 |
| Daiichi Sankyo Inc. | 6 | $140 |
| Tersera Therapeutics LLC | 5 | $131 |
| Pharmaessentia USA Corporation | 5 | $122 |
| Lundbeck LLC | 5 | $106 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| Novartis | 5 | $102 |
| Puma Biotechnology, Inc. | 5 | $100 |
| Invivyd Inc | 3 | $68 |
| Pfizer | 3 | $64 |
| Grifols USA, LLC | 2 | $55 |
| Octapharma USA, Inc. | 2 | $46 |
| GSK | 2 | $44 |
| Eisai Inc. | 2 | $42 |
| Springworks Therapeutics, Inc. | 1 | $39 |
| Merck | 2 | $39 |
| Karyopharm Therapeutics Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Genmab U.S., Inc. | 1 | $33 |
| Organon | 2 | $31 |
| Agios Pharmaceuticals, Inc. | 1 | $29 |
| CSL Behring | 1 | $27 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Bayer | 1 | $24 |
| Argenx US, Inc. | 1 | $24 |
| ADC Therapeutics America, Inc. | 1 | $22 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Morphosys, US Inc. | 1 | $21 |
| GRT US Holding, Inc. | 1 | $21 |
| Iovance Biotherapeutics, Inc. | 1 | $19 |
| Immunocore Limited | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$175
How this compares
$4,878 in reported general payments places this provider in the 90th percentile of 3,828 adult health providers in New York.
Other adult health in New York
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
- Hyo Jin KangNew York$19K
- Monica RicheyNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.